DBF4B and cancer: Immune subtypes (C1: wound healing, C2: interferon-γ dominant, C3: inflammatory, C4: lymphocyte depletion, C5: immune quieting, C6: transforming growth factor-β dominant) correlated with DBF4B expression in 9 cancers (Figure S8): BRCA, COAD, ESCA, HNSC, LGG, LIHC, LUSC, STAD, and UCEC.